Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

NHLBI TOPMed: Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

ABSTRACT: NHLBI TOPMed: Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

PROVIDER: PRJNA588107 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

NHLBI TOPMed: Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Project description:NHLBI TOPMed: Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

| PRJNA588108 | ENA

Subpopulations and intermediate outcome measures in COPD Study (SPIROMICS)

Project description:Subpopulations and intermediate outcome measures in COPD Study (SPIROMICS)

| PRJNA321233 | ENA

Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Project description:Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

| PRJNA835960 | ENA

Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Project description:Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

| PRJNA835959 | ENA

NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene)

Project description:NHLBI TOPMed: Genetic Epidemiology of COPD (COPDGene)

| PRJNA289174 | ENA

NHLBI TOPMed: Boston Early-Onset COPD Study

Project description:NHLBI TOPMed: Boston Early-Onset COPD Study

| PRJNA288739 | ENA

Plasma Metabolomic signatures of COPD in a SPIROMICS cohort

Project description:The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) (ClinicalTrials.gov Identifier: NCT01969344) includes 2,771 subjects, aged 40-80 years with at least 20 pack-years of smoking. An additional 202 subjects were never smokers. Fasting blood drawn at the enrollment visit using a p100 tube. The first 649 subjects who returned for a 5-7 year visit (Visit 5) were selected for this study. The blood profiled were from the year 1 visit.

2020-12-30 | ST001639 | MetabolomicsWorkbench

Homo sapiens

Project description:Subpopulations and intermediate outcome measures in COPD Study (SPIROMICS)

| PRJNA321234 | ENA

Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema

Project description:Plasma Metabolomic signatures of COPD in a SPIROMICS cohort The Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) (ClinicalTrials.gov Identifier: NCT01969344) includes 2,771 subjects, aged 40-80 years with at least 20 pack-years of smoking. An additional 202 subjects were never smokers. Fasting blood drawn at the enrollment visit using a p100 tube. The first 648 subjects who returned for a 5-7 year visit (Visit 5) were selected for this study. The blood profiled were from the year 1 visit. This study is a duplicate of ST001639 (https://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001639) but differs in analysis and contains batch normalized data using median metabolite values.

2022-02-14 | ST002088 | MetabolomicsWorkbench

NHLBI TOPMed: Partners HealthCare Biobank

Project description:NHLBI TOPMed: Partners HealthCare Biobank

| PRJNA300701 | ENA